期刊文献+

Noradrenergic, glutamatergic and dopaminergic systems are implicated in antidepressant-like effect of flavonoids extracted from okra (Abelmoschus esculentus [L.] Moench.) fruit in the forced swimming test

下载PDF
导出
摘要 Okra(Abelmoschus esculentus[L.]Moench.)is one of the most frequently used herbals in East or West Africa,and its various biological activities have been widely studied.Flavonoids extracted from many plants are reported to have neurological properties,e.g antidepressant and antifatigue.However,its neurological protect in antidepressant-like effect of flavonoids extracted from okra have not yet been demonstrated.The present study was aimed at investigating the antidepressant-like eff ect of the flavonoids extracted from okra fruit(FOF)using the forced swimming test(FST)pattern and preliminary exploration its potential mechanism.We also used the open fi eld test(OFT)to estimate the spontaneous locomotor activity.We found that oral administration(p.o.)of FOF(300 mg/kg)alone signifi cantly reduced the immobility time in the FST without changes in locomotor activity in the OPT.The experimental data indicated the antidepressant-like eff ect of FOF involved in noradrenergic,glutamatergic and dopaminergic systems.
出处 《Journal of Polyphenols》 2022年第1期17-31,共15页 多酚杂志(英文)
基金 This research was supported by Shenyang Scientific Project(No.F13-287-1-00) Liaoning Province Natural Science Foundation(No.2014020076).
  • 相关文献

参考文献3

二级参考文献127

  • 1Wang R Yan H Tang XC.Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine[J].中国生物学文摘,2006,20(10):20-20. 被引量:70
  • 2Kessler RC, Bromet EJ. The epidemiology of depression across cultures. Annu Rev Public Health 2013, 34: 119-138.
  • 3Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et aL The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003, 289: 3095-3105.
  • 4Manji HK, Drevets WC, Charney DS. The cellular neurobiology of depression. Nat Med 2001,7: 541-547.
  • 5Belmaker RH, Agam G. Major depressive disorder. N Engl J Med 2008, 358: 55-68.
  • 6Rush A J, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR* D report. Am J Psychiatry 2006, 163: 1905- 1917.
  • 7Berton O, Nestler EJ. New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 2006, 7: 137-151.
  • 8Zarate CA Jr, Brutsche NE, Ibrahim L, Franco-Chaves J; Diazgranados N, Cravchik A, et al. Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial. Biol Psychiatry 2012, 71: 939-946.
  • 9Berman RM, Cappiello A, Anand A, Oren DA, Heninger GF Charney DS, et al. Antidepressant effects of ketamine depressed patients. Biol Psychiatry 2000, 47: 351-354.
  • 10Hirschfeld RM. History and evolution of the monoamine hypothesis of depression. J Clin Psychiatry 2000, 61 Suppl 6: 4-6.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部